Ibuprofen
This medicine should always be taken exactly as described in this patient leaflet or as advised by your doctor or pharmacist.
Ibuprofen Zentiva belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). These medicines have analgesic, antipyretic, and anti-inflammatory effects. Adults and adolescents (12-18 years, from 40 kg body weight): Ibuprofen Zentiva is used for short-term, symptomatic treatment of mild to moderate pain, such as:
Ibuprofen Zentiva is used for acute painful conditions and fever associated with colds. Ibuprofen Zentiva, 400 mg is recommended for use in adults and adolescents from 40 kg body weight (over 12 years of age).
Before starting treatment with Ibuprofen Zentiva, discuss with your doctor or pharmacist:
During ibuprofen treatment, allergic reactions to this medicine have been reported, including breathing difficulties, facial and neck edema (angioedema), chest pain. If the patient notices any of these symptoms, they should stop taking Ibuprofen Zentiva and contact their doctor or emergency services immediately.
Elderly patients
Elderly patients should be aware of the increased risk of adverse reactions, especially gastrointestinal bleeding and perforation, which can be fatal. Ulcers, perforation, and gastrointestinal bleeding
Gastrointestinal bleeding, ulceration, or perforation can occur without warning symptoms, even in patients who have never had such problems before. This can be life-threatening.
The risk of gastrointestinal bleeding, ulceration, or perforation is increased with the use of high doses of ibuprofen. It is also higher in the elderly, for more information see "Elderly patients" in the "How to take Ibuprofen Zentiva" section. The risk is also increased when taking certain other medications concomitantly with ibuprofen (see section "Ibuprofen Zentiva and other medicines").
Impact on the heart and brain
Taking anti-inflammatory and/or pain-relieving medicines, such as ibuprofen, may be associated with a slightly increased risk of heart attack or stroke, particularly when used at high doses. Do not exceed the recommended dose and duration of treatment. Any risk is more likely with high doses and long-term treatment.
Skin reactions
Severe skin reactions have been reported with ibuprofen treatment, including exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). Stop taking Ibuprofen Zentiva and seek medical attention immediately if any symptoms of severe skin reactions occur as described in section 4.
Impact on the kidneys
Ibuprofen may cause kidney function disorders, even in patients who have never had kidney problems before. This can lead to swelling of the feet and, in susceptible individuals, to heart failure or high blood pressure. Ibuprofen may cause kidney damage, especially in patients who already have kidney, heart, or liver disease, or who are taking diuretics, ACE inhibitors, or are elderly.
However, stopping ibuprofen usually leads to recovery. Infections
Ibuprofen Zentiva may mask the symptoms of infection, such as fever and pain. Therefore, Ibuprofen Zentiva may delay the application of appropriate treatment for the infection, which may lead to increased risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If the patient is taking this medicine during an infection and the symptoms of the infection persist or worsen, they should consult their doctor immediately.
Other warnings
Long-term use of any pain-relieving medication for headache can worsen its effectiveness. If, despite (or because of) regular use of pain-relieving medication, headaches occur frequently or daily, consult a doctor before taking another pain-relieving medication. Treatment should be discontinued if medication overuse headache (MOH) is diagnosed. Do not take Ibuprofen Zentiva if you are planning to become pregnant. Consult your doctor first. See also "Pregnancy, breastfeeding, and fertility".
Do not give Ibuprofen Zentiva, 400 mg to children under 40 kg body weight (under 12 years of age). Consult a doctor before giving this medicine to a child if:
If the child has a fever, consult a doctor if:
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, and about any medicines you plan to take. Ibuprofen Zentiva may affect the action of other medicines or other medicines may affect the action of Ibuprofen Zentiva. For example:
If the patient has a sensitive stomach, it is recommended to take this medicine with food. Alcohol should be avoided, as it may enhance the adverse effects of this medicine, particularly those related to the stomach, intestines, or brain.
If you are pregnant, think you may be pregnant, or are planning to have a baby, consult your doctor before taking this medicine.
Pregnancy
Do not take Ibuprofen Zentiva during the last three months of pregnancy, as it may harm the unborn child or cause problems during delivery. It may cause kidney and heart problems in the unborn child. It may increase the risk of bleeding in the mother and child and cause prolongation or delay of labor. During the first six months of pregnancy, do not take Ibuprofen Zentiva unless your doctor considers it absolutely necessary. If treatment is necessary during this period or when trying to conceive, use the lowest possible dose for the shortest possible time. From the 20th week of pregnancy, Ibuprofen Zentiva may cause kidney function disorders in the unborn child if taken for more than a few days. This can lead to low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of the arterial duct (ductal constriction) in the baby's heart. If treatment is required for a longer period, your doctor may recommend additional monitoring.
Breastfeeding
Ibuprofen passes into breast milk, but it is unlikely to affect the breastfed baby when used for short-term treatment. However, if long-term treatment is necessary, breastfeeding should be discontinued.
Fertility
Ibuprofen Zentiva may make it more difficult to become pregnant. Inform your doctor if you are planning to become pregnant or are having problems becoming pregnant. This medicine belongs to a group of medicines (NSAIDs) that may impair female fertility. This effect is reversible after stopping the medicine.
Ibuprofen generally does not affect the ability to drive or use machines. However, as adverse effects such as drowsiness and dizziness may occur after taking high doses of the medicine, the ability to drive or use machines may be impaired. This is especially important when consuming alcohol.
The medicine contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".
This medicine should always be taken exactly as described in the patient leaflet or as advised by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.
How to take Ibuprofen Zentiva
Swallow the tablet with a glass of water. Do not crush, chew, or suck the tablet to avoid irritating the stomach or throat. If the patient has a sensitive stomach, it is recommended to take this medicine with food.
How much to take of Ibuprofen Zentiva
The smallest effective dose should be used for the shortest duration necessary to relieve symptoms. If the patient has an infection, they should consult their doctor immediately if symptoms (such as fever and pain) persist or worsen (see section 2).
Adults:If the patient does not feel better or feels worse after 3 days for fever or migraine headache or 5 days for pain, they should consult their doctor.
Children and adolescents:If it is necessary to use this medicine for more than 3 days or if symptoms worsen, consult a doctor.
The dose of ibuprofen for children and adolescents depends on the patient's age and body weight.
Do not give Ibuprofen Zentiva, 400 mg to adolescents with a body weight below 40 kg or under 12 years of age.
Taking higher doses than recommended may pose a serious risk. Do not take different types of pain-relieving medications at the same time without consulting a doctor.
Mild to moderate pain and acute pain and fever associated with colds
For administration of doses in children, Ibuprofen Zentiva 200 mg should be used.
Adults and adolescents with a body weight of 40 kg or more (over 12 years of age):
Maximum daily dose: 1200 mg.
The dose should be taken as follows:
400 mg tablets: One tablet taken as a single dose or up to 3 times a day. There should be at least 4 to 6 hours between doses. The maximum daily dose should not exceed 3 tablets.
A single dose greater than 400 mg does not provide better pain relief.
Migraine headache
Adults and adolescents with a body weight of 40 kg or more (over 12 years of age):
Maximum daily dose: 1200 mg.
The dose should be taken as follows:
One 400 mg tablet taken as needed, 1 to 3 times a day. There should be at least 4 to 6 hours between doses.
A single dose greater than 400 mg does not provide better pain relief.
Menstrual pain
Adults and adolescents with a body weight of 40 kg or more (over 12 years of age):
Maximum daily dose: 1200 mg.
The dose should be taken as follows:
One 400 mg tablet taken at the first symptoms of menstruation, 1 to 3 times a day. There should be at least 4 to 6 hours between doses.
A single dose greater than 400 mg does not provide better pain relief.
Elderly patients
If the patient is elderly, they should always consult their doctor before taking Ibuprofen Zentiva. If the patient is elderly, they will be more susceptible to adverse reactions, especially gastrointestinal bleeding and perforation, which can be fatal. The doctor will provide appropriate advice.
Impaired liver or kidney function
If the patient has impaired kidney or liver function, they should always consult their doctor before taking Ibuprofen Zentiva.
If the patient has taken more than the recommended dose of Ibuprofen Zentiva or if a child has accidentally taken the medicine, they should always consult their doctor or go to the nearest hospital for advice on possible risks to their health and the actions to be taken.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain blood), headache, ringing in the ears, confusion, and nystagmus. After taking large doses, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, feeling cold, and breathing difficulties have been observed. Additionally, low blood pressure may occur.
Do not take a double dose to make up for a missed dose.
In case of any further doubts about the use of this medicine, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Side effects are more likely to occur with high doses and long-term treatment.
Other side effects that may occur are listed below by frequency of occurrence:
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Frequency not known(frequency cannot be estimated from the available data):
The use of medicines such as Ibuprofen Zentiva may slightly increase the risk of heart attack or stroke. NSAIDs have been reported to cause fluid retention, high blood pressure, and heart failure. Ibuprofen Zentiva may cause a decrease in white blood cell count, and the body's ability to fight infection may be reduced. If the patient develops an infection with symptoms such as fever and serious deterioration of general health or fever with local infection symptoms such as sore throat or mouth ulcers, they should consult their doctor immediately. A blood test will be performed to check for a possible decrease in white blood cell count (agranulocytosis). It is important to inform the doctor that you are taking this medicine.
During ibuprofen treatment, a few cases of meningitis (with symptoms such as stiff neck, headache, nausea, vomiting, fever, or disorientation) have been reported in patients with pre-existing autoimmune disorders, such as systemic lupus erythematosus or mixed connective tissue disease.
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder or its representative in Poland.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a temperature below 25°C. Store in the original packaging to protect from moisture.
Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is ibuprofen. Each tablet contains 400 mg of ibuprofen. The other ingredients are:
Tablet core: microcrystalline cellulose, sodium croscarmellose, hypromellose 2910/5, stearic acid, silicon dioxide, magnesium stearate.
Tablet coating: hypromellose 2910/5, macrogol 300, talc, titanium dioxide (E 171).
White to almost white, round, coated tablets with a diameter of 12 mm. The tablets are packaged in PVC/Aluminum blisters.
Package sizes:
10, 12, 20, 24, 30, 36, 40, 48, 50, 100, 250 coated tablets. Not all pack sizes may be marketed.
Zentiva, k.s., U kabelovny 130, Dolní Měcholupy, 102 37 Prague 10, Czech Republic.
Zentiva, k.s., U kabelovny 130, Dolní Měcholupy, 102 37 Prague 10, Czech Republic. S.C. Zentiva S.A., B-dul Theodor Pallady nr. 50, sector 3, 032266 Bucharest, Romania.
Austria, Estonia, Lithuania, Latvia, Poland | Ibuprofen Zentiva |
Iceland, Finland, Sweden | Ibetin |
Spain | Ibuprofeno Zentiva |
Romania | Inflanor |
Zentiva Poland Sp. z o.o., ul. Bonifraterska 17, 00-203 Warsaw, tel.: +48 22 375 92 00.
Date of last revision of the leaflet:January 2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.